26
|
Schmidt O, Hamelmann E, Vogelberg C, Laki I, Azzi GE, Engel M, Moroni-Zentgraf P, Finnigan H, Vandewalker M. P156 Efficacy, safety and tolerability of once-daily tiotropium respimat® add-on therapy in children with moderate symptomatic asthma. Thorax 2016. [DOI: 10.1136/thoraxjnl-2016-209333.299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
27
|
Vogelberg C, Szefler SJ, Hamelmann E, Boner A, Moroni-Zentgraf P, Engel M, Azzi GE, Finnigan H, Vandewalker M. P155 Safety of tiotropium respimat® add-on therapy in patients aged 6–17 years with symptomatic asthma. Thorax 2016. [DOI: 10.1136/thoraxjnl-2016-209333.298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
28
|
Engel M, Tippkötter N. Einfluss eines Phenazin-Mediators und elektrischen Potenzials auf die Aceton-Butanol-Ethanol-Fermentation. CHEM-ING-TECH 2016. [DOI: 10.1002/cite.201650105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
29
|
El Sayed A, Ibrahim A, Elhassan H, Zuhlke L, Engel M, Karthikeyan G, Teo K, Yusuf S, Mayosi B. PM276 The Global Rheumatic Heart Disease Study (Remedy) – Data From Sudan. Glob Heart 2016. [DOI: 10.1016/j.gheart.2016.03.405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
30
|
Wasserman S, Engel M, Griesel R, Mendelson M. Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: A systematic review and meta-analysis. Int J Infect Dis 2016. [DOI: 10.1016/j.ijid.2016.02.694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
31
|
Seeberger R, Hoffmann J, Freudlsperger C, Berger M, Bodem J, Horn D, Engel M. Intracranial volume (ICV) in isolated sagittal craniosynostosis measured by 3D photocephalometry: A new perspective on a controversial issue. J Craniomaxillofac Surg 2016; 44:626-31. [PMID: 27017102 DOI: 10.1016/j.jcms.2016.01.023] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2015] [Revised: 12/18/2015] [Accepted: 01/27/2016] [Indexed: 10/22/2022] Open
Abstract
BACKGROUND There are still controversies regarding the intracranial volumes in patients with isolated sagittal craniosynostosis compared to a healthy population. This study aimed to compare the intracranial volume of children with sagittal synostosis and scaphocephaly to an age- and gender-matched control cohort using three-dimensional (3D) photogrammetry. METHODS 62 boys and nine girls with sagittal craniosynostosis were included in this study. The intracranial volume was measured at the first clinical presentation. However, 3D photogrammetry was performed at children not younger than 3 months. The 3D photogrammetric data of 547 healthy boys and 287 healthy girls between the ages of 3-10 month was analyzed to establish an age- and gender-matched control group. RESULTS Male patients with sagittal synostosis showed a significantly reduced intracranial volume compared to the reference group. For female patients, the intracranial volume was slightly lower compared to the norm group, but not significantly. CONCLUSIONS Male children with sagittal synostosis showed significantly decreased intracranial volume between the age of 3 and 10 months compared to an age- and gender-matched control group. Female patients in the same age group presented a lower intracranial volume compared to the norm group. Measuring intracranial volume using 3D photogrammetry is a comparable and valuable alternative to CT scans that leads to a significant reduction of radiation exposure to the growing brain.
Collapse
|
32
|
Beck E, Casale T, Hanania NA, Haughney J, Vandewalker M, Meltzer E, Paggiaro P, Engel M, Unseld A, Moroni-Zentgraf P, Kerstjens H. Once-daily tiotropium Respimat®: safety and tolerability results from five Phase III trials in adults with symptomatic asthma. Pneumologie 2016. [DOI: 10.1055/s-0036-1572093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
33
|
Beck E, Dahl R, Szefler SJ, Bernstein J, Vandewalker M, Engel M, Moroni-Zentgraf P, Unseld A, Hamelmann E. Safety and tolerability of once-daily tiotropium Respimat® add-on to at least inhaled corticosteroid maintenance therapy in adolescent patients with moderate or severe symptomatic asthma. Pneumologie 2016. [DOI: 10.1055/s-0036-1572092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
34
|
Dusser D, Dahl R, Casale T, Bleecker E, Pizzichini E, Engel M, Moroni-Zentgraf P, Bour L, Kerstjens H. Efficacité du tiotropium Respimat® chez les adultes atteints d’asthme modéré utilisant ou non des antileucotriènes (LTRA). Rev Mal Respir 2016. [DOI: 10.1016/j.rmr.2015.10.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
35
|
Dahl R, Casale T, Vandewalker M, Schmidt H, Engel M, Moroni-Zentgraf P, Kerstjens HAM. P150 Once-daily tiotropium Respimat® reduces risk of severe asthma exacerbation and asthma worsening in symptomatic asthma, independent of allergic and inflammatory status. Thorax 2015. [DOI: 10.1136/thoraxjnl-2015-207770.287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
36
|
Halpin D, Bateman ED, Paggiaro P, Bleecker ER, Engel M, Moroni-Zentgraf P, Schmidt H, Kerstjens HAM. P148 Once-daily tiotropium Respimat® add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma: Abstract P148 Table 1. Thorax 2015. [DOI: 10.1136/thoraxjnl-2015-207770.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
37
|
Dusser D, Buhl R, Castro M, Kerstjens HAM, Paggiaro P, Engel M, Moroni-Zentgraf P, Unseld A, Bateman ED. P149 Once-daily tiotropium Respimat® add-on to at least ICS in adult patients with symptomatic asthma: pooled safety analysis: Abstract P149 Table 1. Thorax 2015. [DOI: 10.1136/thoraxjnl-2015-207770.286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
38
|
Casale T, Dahl R, Virchow JC, Engel M, Moroni-Zentgraf P, Lühmann R, Kerstjens HAM. P151 Tiotropium Respimat® add-on therapy reduces exacerbation risk in patients with moderate or severe symptomatic asthma, independent of TH2 status: Abstract P151 Table 1. Thorax 2015. [DOI: 10.1136/thoraxjnl-2015-207770.288] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
39
|
Van Tuijl SG, Van Cauteren YJ, Pikhard T, Engel M, Schieveld JN. Management of pediatric delirium in critical illness: a practical update. Minerva Anestesiol 2015; 81:333-341. [PMID: 24762705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Pediatric delirium (PD) is an acute state of brain dysfunction and is often seen in the pediatric intensive care unit (PICU). There is a growing awareness of its clinical interdisciplinary importance. The aim of this article was to describe the three clinical presentations, to evaluate the differential diagnosis and to give a concise and practical update for the pharmacological and non-pharmacological treatment of PD at the PICU, based on recent literature and expert opinions. We discuss an interdisciplinary flow chart which helps the reader dealing with the diagnosis and management of any acute emotional and or behavioral disturbance, of which PD is a special case.
Collapse
|
40
|
Schmidt O, Halpin D, Bateman E, Paggiaro P, Bleecker E, Engel M, Moroni-Zentgraf P, Schmidt H, Kerstjens H. Once-daily tiotropium Respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma. Pneumologie 2015. [DOI: 10.1055/s-0035-1544684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
41
|
Schmidt O, FitzGerald JM, Kerstjens H, Paggiaro P, Ohta K, Ichinose M, Moroni-Zentgraf P, Engel M, Schmidt H, Bateman E. Once-daily tiotropium Respimat add-on to ICS ± LABA improves control across asthma severities. Pneumologie 2015. [DOI: 10.1055/s-0035-1544685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
42
|
Schmidt O, Ohta K, Ichinose M, Tohda Y, Engel M, Moroni-Zentgraf P, Kunimitsu S, Sakamoto W, Adachi M. Once-daily tiotropium Respimat® is well tolerated and efficacious over 52 weeks in Japanese patients with symptomatic asthma receiving inhaled corticosteroids (ICS)± long-acting β2-agonist (LABA): a randomized, double-blind, placebo-controlled study. Pneumologie 2015. [DOI: 10.1055/s-0035-1544686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
43
|
Dusser D, Devillier P, Buhl R, Castro M, Kerstjens H, Paggiaro P, Engel M, Moroni-Zentgraf P, Unseld A, Bateman E. Tolérance du tiotropium Respimat en traitement additionnel d’un traitement continu par CSI±LABA chez des patients adultes ayant un asthme symptomatique : analyse des données groupées. Rev Mal Respir 2015. [DOI: 10.1016/j.rmr.2014.10.409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
44
|
Devillier P, Dusser D, Halpin D, Bateman E, Paggiaro P, Bleecker E, Engel M, Moroni-Zentgraf P, Schmidt H, Kerstjens H. Le tiotropium Respimat en traitement bronchodilatateur additionnel d’un traitement de fond par CSI±LABA réduit le risque d’exacerbation chez les patients asthmatiques adultes non contrôlés. Rev Mal Respir 2015. [DOI: 10.1016/j.rmr.2014.10.408] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
45
|
Paggiaro P, Halpin D, Buhl R, Engel M, Zubek V, Blahova Z, Moroni-Zentgraf P, Pizzichini E. P260 Tiotropium Respimat(R) Add-on To Inhaled Corticosteroids Improves Lung Function In Patients With Symptomatic Mild Asthma: Results From A Phase Iii Trial. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
46
|
Dahl R, Doherty D, Corren J, Karpel J, Kerstjens H, Engel M, Moroni-Zentgraf P, Schmidt H, Hashimoto S. P230 Once-daily Tiotropium Respimat(R) Improves Lung Function In Patients With Severe Symptomatic Asthma Independent Of Leukotriene Modifier Use. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
47
|
Yang WH, Casale T, Bateman ED, Dahl R, Pizzichini E, Vandewalker M, Virchow JC, Engel M, Moroni-Zentgraf PM, Schmidt H, Kerstjens HAM. Tiotropium respimat® add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of TH2 inflammatory status. Allergy Asthma Clin Immunol 2014. [PMCID: PMC4304131 DOI: 10.1186/1710-1492-10-s2-a52] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
48
|
Price D, Engel M, Moroni-Zentgraf P, Schmidt H, Dahl R, Paggiaro P, Vandewalker M, Kerstjens H, Kaplan A. S91 Once-daily tiotropium Respimat(R) add-on to ICS + LABA improves symptom control and reduces exacerbations in patients with symptomatic asthma. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.97] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
49
|
Dahl R, Casale T, Pizzichini E, Vandewalker M, Virchow J, Engel M, Sigmund R, Moroni-Zentgraf P, Kerstjens H. P229 Once-daily Tiotropium Respimat(R) As Add-on To At Least Medium- To High-dose Ics, With Or Without Laba, Improves Lung Function In Patients With Symptomatic Asthma, Independent Of Allergic Status. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.357] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
50
|
Haughney J, Vandewalker M, Meltzer E, Paggiaro P, Engel M, Unseld A, Moroni-Zentgraf P, Kerstjens H. P231 Once-daily Tiotropium Respimat(R): Safety And Tolerability Results From Five Phase Iii Trials In Adults With Symptomatic Asthma. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.359] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|